DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Huang W-S, Metcalf CA, Sundaramoorthi R. , et al.
Discovery of 3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenylbenzamide (AP24534), a potent, orally active pan-inhibitor of breakpoint cluster region-abelson (BCR-ABL) kinase including the T315I gatekeeper mutant.
J Med Chem 2010;
53 (12) 4701-4719
We do not assume any responsibility for the contents of the web pages of other providers.